The Effects of Stroboscopic Visual Conditions on Gait and Lower Limb Muscle Activity in Individuals With Chronic Ankle Instability

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorSahmyook University

About this trial

This interventional study will investigate the effects of stroboscopic visual conditions on gait patterns and lower limb muscle activation in adults with chronic ankle instability (CAI). CAI often results in impaired sensorimotor control, leading to altered gait strategies such as slower walking speed, shorter step length, and increased visual reliance. Stroboscopic glasses intermittently restrict visual input, potentially reducing visual dependence and enhancing proprioceptive feedback.

Participants will complete walking trials under three randomized visual conditions: high-frequency stroboscopic, low-frequency stroboscopic, and no-glasses control. Gait parameters will be measured using the GAITRite system, and surface electromyography (sEMG) will record activation of the tibialis anterior, peroneus longus, and gastrocnemius muscles. Findings may provide insight into sensorimotor adaptation mechanisms and inform rehabilitation strategies to improve functional stability in individuals with CAI.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals with a Cumberland Ankle Instability Tool (CAIT) score of less than 24

Individuals diagnosed with ankle sprain or instability within the past 6 months

Disqualifiers

Individuals who have undergone lower limb surgery or experienced a fracture due to ankle trauma within the past 6 months

Individuals with systemic diseases, such as cardiovascular disorders, that may affect balance

Individuals who have difficulty understanding or following instructions during assessment or training

Trial design

Design model

Single group

Treatments tested in this trial

  • Stroboscopic Visual Conditions

    Behavioral

    Participants will perform walking trials under three visual conditions: high-frequency stroboscopic glasses, low-frequency stroboscopic glasses, and no-glasses control. Each participant will complete three 5-meter walking trials per condition, with the order of conditions randomized. Gait parameters will be recorded using the GAITRite walkway system, and muscle activity will be measured using surface electromyography.

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: Single Group - Chronic Ankle InstabilityExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Gait Velocity (cm/s) Under Different Stroboscopic Visual Conditions

Gait velocity will be measured using the GAITRite system under three visual conditions: high-frequency stroboscopic, low-frequency stroboscopic, and no stroboscopic. Each participant will perform three walking trials per condition over a 5-meter walkway. The average gait velocity (cm/s) will be calculated for each condition.

Time frame
Day 1 (single experimental session; immediately after each walking condition)

Secondary outcomes

1

Change in Step Length (cm) Under Different Stroboscopic Visual Conditions

Step length will be measured using the GAITRite system under three visual conditions. The average value (cm) will be calculated for each condition.

Time frame
Day 1 (single experimental session; immediately after each walking condition)
2

Change in Step Width (cm) Under Different Stroboscopic Visual Conditions

Step width will be measured using the GAITRite system under three visual conditions.

Time frame
Day 1 (single experimental session; immediately after each walking condition)
3

Change in Swing Phase (%) Under Different Stroboscopic Visual Conditions

Swing phase duration as a percentage of the gait cycle will be measured using the GAITRite system under three visual conditions.

Time frame
Day 1 (single experimental session; immediately after each walking condition)
4

Change in Single Limb Support (%) Under Different Stroboscopic Visual Conditions

Single limb support duration as a percentage of the gait cycle will be measured.

Time frame
Day 1 (single experimental session; immediately after each walking condition)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: